Matinas BioPharma Holdings Inc. (MTNB) PT Raised to $5 at Maxim Group
Tweet Send to a Friend
Maxim Group analyst Jason McCarthy raised the price target on Matinas BioPharma Holdings Inc. (NYSE: MTNB) to $5.00 (from $2.00) ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
